Drugs / CT101a
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05256277 | Dec 2021 → Aug 2022 | acute myeloid leukemia | Zhejiang University | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CT101a | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05256277 ↗ |